Vor Biopharma Inc. (VOR)
NasdaqGS · Biotechnology
Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.
Price history
Daily closes and volumeAI Analysis Generated from the indicator readings below. Educational only.
Vor Biopharma Inc. is trading at $19.68, down 5.88% on the session. The 50 day average sits at $20.99 and the 200 day at $17.21, which puts the stock in a uptrend. RSI is at 41.8, which reads as weak, and MACD is bullish crossover. Volume is below average.
The nearest support is around $17.86 with resistance near $19.79, so that band frames the current range. Average daily movement is roughly $1.17, or about 6.0% of the share price, which is what any stop placement has to allow for. The overall health score of 50 out of 100 combines a trend score of 53, momentum of 55 and a risk score of 38.
Technical indicators
AI trade signals on VOR
All signals| Date | Setup | Entry | Target | Stop | R:R | Status |
|---|---|---|---|---|---|---|
| Sep 28 | Bounce | ••.•• | ••.•• | ••.•• | 2.03:1 | Expired |
About Vor Biopharma Inc.
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Company website